PA8604101A1 - Derivados de imidazol - Google Patents
Derivados de imidazolInfo
- Publication number
- PA8604101A1 PA8604101A1 PA20048604101A PA8604101A PA8604101A1 PA 8604101 A1 PA8604101 A1 PA 8604101A1 PA 20048604101 A PA20048604101 A PA 20048604101A PA 8604101 A PA8604101 A PA 8604101A PA 8604101 A1 PA8604101 A1 PA 8604101A1
- Authority
- PA
- Panama
- Prior art keywords
- same
- imidazol derivatives
- disorders
- mglur5
- imidazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A DERIVADOS DEL IMIDAZOL QUE SON ANTAGONISTAS DEL RECEPTOR MGLUR5, LOS CUALES ESTAN REPRESENTADOS POR LA FORMULA GENERAL I, EN DONDE R1,R2,R3 Y R4 SON COMO SE HAN DEFINIDO EN LA ESPECIFICACION, A UN PROCEDIMIENTO PARA LA OBTENCION DE LOS MISMOS, ASI COMO TAMBIEN A LAS SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS PARA LA ELABORACION DE UN MEDICAMENTO PARA EL TRATAMIENTO O PREVENCION DE TRANSTORNOS INDUCIDOS POR EL RECEPTOR MGlUR5, TALES COMO TRANSTORNOS NEUROLOGICOS AGUDOS Y/O CRNICOS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03012200 | 2003-06-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8604101A1 true PA8604101A1 (es) | 2004-12-16 |
Family
ID=33483899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20048604101A PA8604101A1 (es) | 2003-06-05 | 2004-06-02 | Derivados de imidazol |
Country Status (39)
| Country | Link |
|---|---|
| US (3) | US7332510B2 (es) |
| EP (1) | EP1636206B1 (es) |
| JP (1) | JP4401384B2 (es) |
| KR (1) | KR100778948B1 (es) |
| CN (1) | CN100408572C (es) |
| AR (1) | AR044478A1 (es) |
| AT (1) | ATE377008T1 (es) |
| AU (1) | AU2004245208B2 (es) |
| BR (1) | BRPI0411095B8 (es) |
| CA (1) | CA2527315C (es) |
| CL (1) | CL2004001347A1 (es) |
| CR (1) | CR8094A (es) |
| CY (1) | CY1107856T1 (es) |
| DE (1) | DE602004009796T2 (es) |
| DK (1) | DK1636206T3 (es) |
| EA (1) | EA010577B1 (es) |
| EC (1) | ECSP056202A (es) |
| ES (1) | ES2294504T3 (es) |
| GT (1) | GT200400117A (es) |
| HK (1) | HK1093070A1 (es) |
| HN (1) | HN2004000208A (es) |
| HR (1) | HRP20070529T3 (es) |
| IL (1) | IL171930A (es) |
| MA (1) | MA27881A1 (es) |
| MX (1) | MXPA05013149A (es) |
| MY (2) | MY137272A (es) |
| NO (1) | NO332143B1 (es) |
| NZ (1) | NZ543637A (es) |
| PA (1) | PA8604101A1 (es) |
| PE (1) | PE20050162A1 (es) |
| PL (1) | PL1636206T3 (es) |
| PT (1) | PT1636206E (es) |
| RS (1) | RS53183B (es) |
| SI (1) | SI1636206T1 (es) |
| TN (2) | TNSN05309A1 (es) |
| TW (1) | TWI338007B (es) |
| UA (1) | UA80888C2 (es) |
| WO (1) | WO2004108701A1 (es) |
| ZA (2) | ZA200509807B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7531529B2 (en) | 2003-06-05 | 2009-05-12 | Roche Palo Alto Llc | Imidazole derivatives |
| UA80888C2 (en) * | 2003-06-05 | 2007-11-12 | Hoffmann La Roche | Imidazole derivatives as glutmate receptor antagonists |
| US7452909B2 (en) | 2003-09-04 | 2008-11-18 | Hoffman-La Roche Inc. | Imidazole derivatives |
| BRPI0511678A (pt) | 2004-06-01 | 2008-01-08 | Hoffmann La Roche | piridin-4-il-etinil-imidazóis e pirazóis como antagonistas de receptor de mglu5 |
| GB0514296D0 (en) * | 2005-07-12 | 2005-08-17 | Novartis Ag | Organic compounds |
| DE102006011574A1 (de) | 2006-03-10 | 2007-10-31 | Grünenthal GmbH | Substituierte Imidazo[2,1-b]thiazol-Verbindungen und ihre Verwendung zur Herstellung von Arzneimitteln |
| AU2007336369B2 (en) * | 2006-12-21 | 2013-01-17 | F. Hoffmann-La Roche Ag | Polymorphs of a mGluR5 receptor antagonist |
| US8334287B2 (en) * | 2009-07-17 | 2012-12-18 | Hoffmann-La Roche Inc. | Imidazoles |
| US20120040008A1 (en) | 2010-08-11 | 2012-02-16 | Ashish Chatterji | Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists |
| US20120039999A1 (en) * | 2010-08-11 | 2012-02-16 | Ashish Chatterji | Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists |
| MX2013010698A (es) | 2011-03-18 | 2014-02-17 | Novartis Ag | Combinaciones de activadores del receptor de acetil-colina nicotinico alfa-7 y antagonistas del receptor de glutamato metabotropico 5 (mglur5) para usarse en la discinesia inducida por dopamina en la enfermedad de parkinson. |
| EP2909180B1 (en) * | 2012-10-18 | 2016-10-05 | F. Hoffmann-La Roche AG | Ethynyl derivatives as modulators of mglur5 receptor activity |
| CA2879489A1 (en) * | 2012-10-18 | 2014-04-24 | F.Hoffmann-La Roche Ag | Ethynyl derivatives as modulators of mglur5 receptor activity |
| EA201891948A1 (ru) * | 2016-03-30 | 2019-04-30 | Синнтаксис Аб | Отрицательные аллостерические модуляторы метаботропного глутаматного рецептора 5 для применения в лечении зрелых повреждений головного мозга |
| CA3180794A1 (en) * | 2020-06-05 | 2021-12-09 | George GARIBALDI | Methods of treatment of tuberous sclerosis complex |
| AR123108A1 (es) | 2020-07-30 | 2022-10-26 | Noema Pharma Ag | Métodos para el tratamiento de la neuralgia del trigémino |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0079312A3 (de) * | 1981-11-11 | 1984-04-25 | Ciba-Geigy Ag | Heterocyclische Acetylenverbindungen |
| TW544448B (en) * | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
| JP4815083B2 (ja) * | 1999-08-31 | 2011-11-16 | メルク・シャープ・エンド・ドーム・コーポレイション | 複素環化合物およびそれの使用方法 |
| CA2416442C (en) * | 2000-07-24 | 2010-06-08 | Krenitsky Pharmaceuticals, Inc. | Substituted 5-alkynyl pyrimidines having neurotrophic activity |
| CN1257894C (zh) | 2000-12-04 | 2006-05-31 | 弗·哈夫曼-拉罗切有限公司 | 作为谷氨酸受体拮抗剂的苯基乙烯基或苯基乙炔基衍生物 |
| AU2002360621B2 (en) * | 2001-12-19 | 2007-01-25 | Merck & Co., Inc. | heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5 |
| US20070060618A1 (en) * | 2002-10-24 | 2007-03-15 | Merck & Co., Inc. | Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
| TWI292318B (en) * | 2003-03-10 | 2008-01-11 | Hoffmann La Roche | Imidazol-4-yl-ethynyl-pyridine derivatives |
| UA80888C2 (en) * | 2003-06-05 | 2007-11-12 | Hoffmann La Roche | Imidazole derivatives as glutmate receptor antagonists |
| US7091222B2 (en) * | 2003-07-03 | 2006-08-15 | Hoffmann-La Roche Inc. | Imidazole derivatives |
-
2004
- 2004-01-06 UA UAA200512695A patent/UA80888C2/uk unknown
- 2004-06-01 EP EP04739484A patent/EP1636206B1/en not_active Expired - Lifetime
- 2004-06-01 KR KR1020057023137A patent/KR100778948B1/ko active IP Right Grant
- 2004-06-01 NZ NZ543637A patent/NZ543637A/en unknown
- 2004-06-01 DK DK04739484T patent/DK1636206T3/da active
- 2004-06-01 BR BRPI0411095A patent/BRPI0411095B8/pt active IP Right Grant
- 2004-06-01 RS YU20050892A patent/RS53183B/en unknown
- 2004-06-01 WO PCT/EP2004/005881 patent/WO2004108701A1/en active IP Right Grant
- 2004-06-01 AT AT04739484T patent/ATE377008T1/de active
- 2004-06-01 CA CA2527315A patent/CA2527315C/en not_active Expired - Lifetime
- 2004-06-01 CN CNB2004800156669A patent/CN100408572C/zh not_active Expired - Lifetime
- 2004-06-01 MX MXPA05013149A patent/MXPA05013149A/es active IP Right Grant
- 2004-06-01 SI SI200430525T patent/SI1636206T1/sl unknown
- 2004-06-01 DE DE602004009796T patent/DE602004009796T2/de not_active Expired - Lifetime
- 2004-06-01 ES ES04739484T patent/ES2294504T3/es not_active Expired - Lifetime
- 2004-06-01 PT PT04739484T patent/PT1636206E/pt unknown
- 2004-06-01 PL PL04739484T patent/PL1636206T3/pl unknown
- 2004-06-01 JP JP2006508238A patent/JP4401384B2/ja not_active Expired - Lifetime
- 2004-06-01 EA EA200501887A patent/EA010577B1/ru not_active IP Right Cessation
- 2004-06-01 AU AU2004245208A patent/AU2004245208B2/en not_active Expired
- 2004-06-02 PE PE2004000558A patent/PE20050162A1/es active IP Right Grant
- 2004-06-02 US US10/858,969 patent/US7332510B2/en active Active
- 2004-06-02 TW TW093115811A patent/TWI338007B/zh active
- 2004-06-02 PA PA20048604101A patent/PA8604101A1/es unknown
- 2004-06-02 CL CL200401347A patent/CL2004001347A1/es unknown
- 2004-06-03 AR ARP040101908A patent/AR044478A1/es active IP Right Grant
- 2004-06-03 GT GT200400117A patent/GT200400117A/es unknown
- 2004-06-03 HN HN2004000208A patent/HN2004000208A/es unknown
- 2004-06-03 MY MYPI20042150A patent/MY137272A/en unknown
-
2005
- 2005-05-27 MY MYPI20052424A patent/MY143353A/en unknown
- 2005-11-13 IL IL171930A patent/IL171930A/en active IP Right Grant
- 2005-11-14 CR CR8094A patent/CR8094A/es unknown
- 2005-11-18 NO NO20055465A patent/NO332143B1/no unknown
- 2005-12-01 TN TNP2005000309A patent/TNSN05309A1/fr unknown
- 2005-12-02 EC EC2005006202A patent/ECSP056202A/es unknown
- 2005-12-02 ZA ZA200509807A patent/ZA200509807B/en unknown
- 2005-12-09 MA MA28648A patent/MA27881A1/fr unknown
-
2006
- 2006-11-21 ZA ZA200609681A patent/ZA200609681B/xx unknown
- 2006-11-27 TN TNP2006000391A patent/TNSN06391A1/fr unknown
- 2006-12-18 HK HK06113874A patent/HK1093070A1/xx unknown
-
2007
- 2007-10-31 US US11/930,258 patent/US8481548B2/en active Active
- 2007-11-20 HR HR20070529T patent/HRP20070529T3/xx unknown
- 2007-12-13 US US11/955,421 patent/US7973165B2/en active Active
-
2008
- 2008-01-11 CY CY20081100047T patent/CY1107856T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR8094A (es) | Derivados de imidazol antagonistas del receptor de glutamato | |
| DOP2009000258A (es) | Compuestos amino-heterociclicos | |
| UY32391A (es) | Compuestos amino-heterocíclicos | |
| UY28752A1 (es) | Agentes terapeuticos | |
| SV2006002055A (es) | Compuestos de imidazol para el tratamiento de trastornos neurodegenerativos ref. pc32054a | |
| PA8524401A1 (es) | DERIVADOS DE 4-Fenil-piridin | |
| UY28144A1 (es) | Agentes terapéuticos | |
| ECSP088396A (es) | Derivados de piperidin-4-il-piridazin-3-ilamina como antagonistas de los receptores 2 de dopamina de rápida disociación | |
| GT200500375A (es) | Derivados de piperidina y su uso como agentes antiinflamatorios | |
| ECSP066391A (es) | [1,8] naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia | |
| UY28374A1 (es) | Agentes terapéuticos | |
| UY30377A1 (es) | Inhibidores triciclicos fusionados de sulfonamida de gama-secretasa | |
| DOP2005000038A (es) | Derivados de piridilo y su uso como antagonistas del receptor mglu5" | |
| UY28376A1 (es) | Agentes terapéuticos | |
| CY1113759T1 (el) | Ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2 | |
| UY28839A1 (es) | Agentes terapeuticos | |
| ECSP034810A (es) | Derivados heterociclilalcoxi-, -alquiltio- y - alquilaminobenzazol tales como ligandos 5-hidroxitriptamina-6 | |
| BRPI0411661A (pt) | derivados de n-fenil-piperazina e métodos de profilaxia ou tratamento de doenças associadas com o receptor 5ht 2c | |
| UY31322A1 (es) | Amidas heterocíclicas y sus métodos de uso-975 | |
| PA8527901A1 (es) | Derivados de quinazolin como un antagonista del adrenèrgico alfa-1 | |
| CR9436A (es) | Derivados de aril 1,4-pirazina sustituidos | |
| UY30577A1 (es) | Derivados de éter diarilico y usos de los mismos | |
| UY29734A1 (es) | Piperazinas bicíclicas como antagonistas de receptores de glutamato metabotrópicos | |
| SV2007002357A (es) | Derivado de quinolina, su uso, preparacion y medicamento que lo contiene ref. p-sv-79232/ug | |
| UY27544A1 (es) | Derivados de piperazina desestabilizantes del receptor de andrógenos |